NEJM: Mirikizumab is Highly Effective in Treating Ulcerative Colitis and Safely Maintaining Remission.

Published Date: 03 Jul 2023

Mirikizumab as Induction and Maintenance Therapy for Ulcerative Colitis is an original article that was published in the New England Journal of.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Does pollution cause cancer?

2.

AI is equally capable of reading breast cancer scans as human radiologists.

3.

EVP Beats Cisplatin for Resectable MIBC

4.

New research points out a promising strategy for treating metastatic medulloblastoma

5.

Academics + Pharma = Big Bucks; New CAR-T Warnings; Patients Seek Cancer Tests.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot